Design and In Silico Validation of a Novel MZF-1-Based Multi-Epitope Vaccine to Combat Metastatic Triple Negative Breast Cancer

Immunotherapy is emerging as a potential therapeutic strategy for triple negative breast cancer (TNBC) owing to the immunogenic landscape of its tumor microenvironment. Interestingly, peptide-based cancer vaccines have garnered a lot of attention as one of the most promising cancer immunotherapy reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnamoorthy, HemaNandini Rajendran, Karuppasamy, Ramanathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051597/
https://www.ncbi.nlm.nih.gov/pubmed/36992161
http://dx.doi.org/10.3390/vaccines11030577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051597/
https://www.ncbi.nlm.nih.gov/pubmed/36992161
http://dx.doi.org/10.3390/vaccines11030577

Ejemplares similares